| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.0003 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.096 | 0.001 |